Buscar
Mostrando ítems 1-10 de 1312
Cut-off Point of Ki-67 Proliferation Marker in Differentiating Premalignant and Malignant Prostatic Lesions
(Academia Nacional de Medicina venezolana., 2022)
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
(HOSPITAL CLINICAS, UNIV SAO PAULOSAO PAULO, 2012)
OBJECTIVE: Differentiation between benign and malignant ovarian neoplasms is essential for creating a system for patient referrals. Therefore, the contributions of the tumor markers CA125 and human epididymis protein 4 ...
Tissue distribution and differential expression of melanocortin i receptor, a malignant melanoma marker
(H K LEWIS AND CO, LTD, 2002)
Cancer stem cell genomics: the quest for early markers of malignant progression
(Expert Reviews, 2009-09-01)
Biologically distinct populations of neoplastic stem cells have been identified in a variety of human cancers, in which they are associated with the initial steps of tumorigenesis. the intrinsic properties of self-renewal, ...
HE4 can help discriminate women with malignant ovarian tumors only if CA125 levels are elevated
(Wichtig EditoreMilanItália, 2013)
GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker
(Faculdade de Medicina / USP, 2011)
OBJECTIVE: To analyze glucose transporter 1 expression patterns in malignant tumors of various cell types and evaluate their diagnostic value by immunohistochemistry. INTRODUCTION: Glucose is the major source of energy for ...
Usefulness of protein-based salivary markers in the diagnosis of oral potentially malignant disorders: A systematic review and meta-analysis
(2021-01-01)
By using a meta-analytical approach, this study aimed to analyse the diagnostic capacity of protein-based biomarkers in saliva for the differential diagnosis of oral potentially malignant disorders (OPMDs) and oral squamous ...